Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

CTHRC1 helps sweat glands recover by rebuilding nearby blood vessels.

Using polyethylenimine-DNA to deliver the hTERT gene can stimulate hair growth and may be useful in treating hair loss, but there could be potential cancer risks.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

DP cells can help in hair growth and regenerative medicine.

Growth factors in skin increase with age, aiding development and healing.

Chemotherapy for male germ cell tumors often leads to hypogonadism and related symptoms.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Vitamin D receptor helps prevent skin tumors.

Blocking IL-8 can reduce skin rashes from cancer treatment.

The TGF-β family helps control how cells change and move, affecting skin, hair, and organ development.

Dihydrotestosterone increases certain inflammatory signals in skin cells, potentially contributing to acne.

Blocking TGFβ can help treat fibrotic skin conditions by promoting fat cell formation.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Lymphotoxin-β is crucial for proper skin development in embryos.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

Aδ-LTMRs have complex synapses with glycine, while Aβ-LTMRs have simpler ones.

Toll-like receptor 3 helps repair the skin barrier after UV damage.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Activating β-catenin in certain skin cells speeds up hair growth in mice.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Beard cells, unlike scalp cells, produce growth factors in response to testosterone, which may explain differences in hair growth.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

GLI2 increases follistatin production in human skin cells.

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

PDGF-D boosts stem cell growth and movement, enhancing hair regeneration.

Somatostatin may help protect hair follicles from immune attacks.